Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses

International Archives of Allergy and Immunology

Volumn 137, Issue 3, 2005, Pages 219-228

  Trujillo Vargas, Claudia Milena ^b   Ramirez Pineda, José Robinson ^a   Palmetshofer, Alois ^b   Grunewald, Susanne ^b   Moll, Heidrun ^b   Berberich, Christoph ^b   Erb, Klaus Joseph ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Atopic asthma; Dendritic cells; Th2 immune responses; Vaccination

Indexed keywords

DENDRITIC CELL VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; OLIGODEOXYNUCLEOTIDE; OVALBUMIN; ALLERGEN; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN G; OLIGODEOXYRIBONUCLEOTIDE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CPG ISLAND; DENDRITIC CELL; EOSINOPHILIA; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LANGERHANS CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TH1 CELL; VACCINATION; ANIMAL; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TH2 CELL;

ALLERGENS; ANIMALS; BASE SEQUENCE; CYTOKINES; DENDRITIC CELLS; EOSINOPHILIA; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; MYELOID CELLS; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; TH2 CELLS; VACCINES;

EID: 23044476200     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086334     Document Type: Article

References (27)

1. Maddox L, Schwartz DA: The pathophysiology of asthma. Annu Rev Med 2002;53:477-498.
2. Lambrecht BN, Hammad H: Taking our breath away: Dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 2003;3:994-1003.
3. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA: Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090-4097.
4. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000;106:551-559.
5. Sung S, Rose CE, Fu SM: Intratracheal priming with ovalbumin- and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J Immunol 2001;166:1261-1271.
6. Graffi SJ, Dekan G, Stingl G, Epstein MM: Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol 2002;103:176-184.
7. Berger TG, Schultz ES: Dendritic cell-based immunotherapy. Curr Top Microbiol Immunol 2003;276:163-197.
8. Ramirez-Pineda JR, Frohlich A, Berberich C, Moll H: Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC. J Immunol 2004;172:6281-6289.
9. Erb KJ, Wohlleben G: Novel vaccines protecting against the development of allergic disorders: A double-edged sword? Curr Opin Immunol 2002;14:633-643.
10. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223:77-92.
11. Wohlleben G, Muller J, Tatsch U, Hambrecht C, Herz U, Renz H, Schmitt E, Moll H, Erb KJ: Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airways and the development of airway eosinophilia. J Immunol 2003;170:4601-4611.
12. Berberich C, Ramirez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H: Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J Immunol 2003;170:3171-3179.
13. Grunewald SM, Hahn C, Wohlleben G, Teufel M, Major T, Moll H, Bröcker E-B, Erb KJ: Infection with influenza A virus leads to Flu antigen-induced cutaneous anaphylaxis in mice. J Invest Dermatol 2002;118:645-651.
14. Hemmi H, Kaisho T, Takeda K, Akira S: The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003;170:3059-3064.
15. Morokata T, Ishikawa J, Ida K, Yamada T: C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses. Immunology 1999;98:345-351.
16. Major T, Wohlleben G, Reibetanz B, Erb KJ: Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses. Vaccine 2002;20:1532-1540.
17. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G: Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-569.
18. De Heer HJ, Hammad H, Soullie T, Hijdra D, Vos N, Willart MA, Hoogsteden HC, Lambrecht BN: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004;200:89-98.
19. Ovary Z, Vaz NM, Warner NL: Passive anaphylaxis in mice with γG antibodies. V. Competitive effects of different immunoglobulins and inhibition of reactions with antiglobulin sera. Immunology 1970;19:715-727.
20. Faquim-Mauro EL, Coffman RL, Abrahamsohn IA, Macedo MS: Mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J Immunol 1999;163:3572-3576.
21. Faquim-Mauro EL, Macedo MS: Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants. Int Immunol 2000;12:1733-1740.
22. Faquim-Mauro EL, Jacysyn JF, Macedo MS: Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: Relevance of proper glycosylation of the molecule. Immunobiology 2003;207:169-177.
23. Hammad H, de Heer HJ, Soullie T, Angeli V, Trottein F, Hoogsteden HC, Lambrecht BN: Activation of peroxisome proliferator-activated receptor-γ in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am J Pathol 2004;164:263-271.
24. Kuipers H, Hijdra D, De Vries VC, Hammad H, Prins JB, Coyle AJ, Hoogsteden HC, Lambrecht BN: Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J Immunol 2003;171:3645-3654.
25. Chiang DJ, Ye YL, Chen WL, Lee YL, Hsu NY, Chiang BL: Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation. Am J Respir Crit Care Med 2003;168:575-580.
26. Deurloo DT, van Esch BC, Hofstra CL, Nijkamp FP, van Oosterhout AJ: CTLA4-IgG reverses asthma manifestations in a mild but not in a more 'severe' ongoing murine model. Am J Respir Cell Mol Biol 2001;25:751-760.
27. Schmitz N, Kurrer M, Kopf M: The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol 2003;33:991-1000.